The new drug has been proven safe and effective in relieving pain and inflammation associated with osteoarthritis.
The FDA has approved India-based Cronus Pharma Specialties’ Carprofen Chewable Tablets (a generic version of Rimadyl—Zoetis PetCare) for dogs.
This nonsteroidal anti-inflammatory drug (NSAID) relieves pain and inflammation associated with osteoarthritis and helps control postoperative pain associated with soft tissue and orthopedic surgeries, according to the Freedom of Information Summary Original Abbreviated New Animal Drug Application.
These tablets can be administered once daily (2 mg/lb of body weight) or twice daily (1 mg/lb). To control postoperative pain, the FDA recommends administering this drug approximately 2 hours before a procedure.
Carprofen Chewable Tablets are scored (except for the unscored 37.5-mg strength), and contain 25, 37.5, 50, 75, or 100 mg of carprofen per tablet. Each tablet size is packaged in bottles containing 60 or 180 tablets.
Carprofen Chewable Tablets should not be used in dogs exhibiting previous hypersensitivity to carprofen and is not intended for use in food-producing animals or in humans.
Adverse reactions to carprofen may include decreased appetite, vomiting, diarrhea, dark or tarry stools, increased water consumption, increased urination, pale gums due to anemia, yellowing of gums, skin or white of the eye due to jaundice, lethargy, incoordination, seizure, or behavioral changes. In rare cases, sudden serious adverse reactions can result in death.
For more information about this new drug, click here.